LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Expansion Passage Bio has recently expanded its team and launched the Tachi Yamada Scholarship Program. Leveraging these expansions, there's an opportunity to build relationships with new hires to introduce the company's genetic therapies for neurodegenerative diseases.

Cutting-edge Therapies With the development of PBFT02 targeting neurodegenerative conditions, Passage Bio offers a unique one-time therapy. This innovation presents a sales opportunity to engage healthcare providers looking to explore advanced treatment options for their patients.

Financial Stability Despite being within the $10M - $50M revenue range, Passage Bio's funding of $154M indicates strong financial backing. This financial stability can be highlighted in sales pitches to reassure potential partners or investors about the company's long-term viability.

Inducement Award Recognition Passage Bio granting an inducement award to a new employee demonstrates a culture of recognition and encouragement. Capitalizing on this positive employee engagement can be a sales strategy to attract partners who value a supportive work environment.

Clinical Data Success The positive interim clinical data from the upliFT-D trial showcases Passage Bio's progress in transforming CNS disorder treatments. Sales discussions can emphasize these successful clinical outcomes to instill confidence in potential collaborators or investors.

Similar companies to Passage Bio

Passage Bio Tech Stack

Passage Bio uses 8 technology products and services including Backbone.js, RequireJS, X-Content-Type-Options, and more. Explore Passage Bio's tech stack below.

  • Backbone.js
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • X-Content-Type-Options
    Miscellaneous
  • Windows Server
    Operating Systems
  • New Relic
    Real User Monitoring
  • FedEx
    Transportation And Fleet Management
  • UPS
    Transportation And Fleet Management
  • Nginx
    Web Servers

Media & News

Passage Bio's Email Address Formats

Passage Bio uses at least 1 format(s):
Passage Bio Email FormatsExamplePercentage
FLast@passagebio.comJDoe@passagebio.com
49%
First.Last@passagebio.comJohn.Doe@passagebio.com
1%
Last@passagebio.comDoe@passagebio.com
1%
FLast@passagebio.comJDoe@passagebio.com
49%

Frequently Asked Questions

Where is Passage Bio's headquarters located?

Minus sign iconPlus sign icon
Passage Bio's main headquarters is located at 2005 Market Street 39th Floor Philadelphia, Pennsylvania 19103 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Passage Bio's stock symbol?

Minus sign iconPlus sign icon
Passage Bio is a publicly traded company; the company's stock symbol is PASG.

What is Passage Bio's official website and social media links?

Minus sign iconPlus sign icon
Passage Bio's official website is passagebio.com and has social profiles on LinkedIn.

How much revenue does Passage Bio generate?

Minus sign iconPlus sign icon
As of November 2024, Passage Bio's annual revenue reached $35M.

What is Passage Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Passage Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Passage Bio have currently?

Minus sign iconPlus sign icon
As of November 2024, Passage Bio has approximately 84 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: W. C.Chief Executive Officer And President: B. G.Chief Technical Officer: A. F.. Explore Passage Bio's employee directory with LeadIQ.

What industry does Passage Bio belong to?

Minus sign iconPlus sign icon
Passage Bio operates in the Biotechnology Research industry.

What technology does Passage Bio use?

Minus sign iconPlus sign icon
Passage Bio's tech stack includes Backbone.jsRequireJSX-Content-Type-OptionsWindows ServerNew RelicFedExUPSNginx.

What is Passage Bio's email format?

Minus sign iconPlus sign icon
Passage Bio's email format typically follows the pattern of . Find more Passage Bio email formats with LeadIQ.

How much funding has Passage Bio raised to date?

Minus sign iconPlus sign icon
As of November 2024, Passage Bio has raised $154M in funding. The last funding round occurred on Jan 21, 2021 for $154M.

When was Passage Bio founded?

Minus sign iconPlus sign icon
Passage Bio was founded in 2017.
Passage Bio

Passage Bio

Biotechnology ResearchPennsylvania, United States51-200 Employees

We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. 

Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions.

Section iconCompany Overview

Headquarters
2005 Market Street 39th Floor Philadelphia, Pennsylvania 19103 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PASG
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $154M

    Passage Bio has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $154M.

  • $10M$50M

    Passage Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $154M

    Passage Bio has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $154M.

  • $10M$50M

    Passage Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.